---
schema_version: "secwatch.filing_event.v1"
accession: "0001640334-26-000461"
form_type: "8-K"
ticker: "ARTL"
cik: "0001621221"
company_name: "ARTELO BIOSCIENCES, INC."
filed_at: "2026-03-17T23:59:59+00:00"
generated_at: "2026-05-15T10:28:01.820326+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Artelo Biosciences completes 1-for-3 reverse split; FY2025 net loss $12.9M, going concern

## Summary
- 1-for-3 reverse stock split effective March 10, 2026; shares reduced from 2.1M to ~708k.
- FY2025 net loss of $12.9M, up from $9.8M in FY2024; accumulated deficit reaches $63M.
- Cash and cash equivalents of $0.6M at Dec 2025; auditor includes going concern qualification.
- Loss on debt extinguishment totaled $1.158M ($825k + $333k related party) in FY2025.
- Convertible notes issued at 12% interest; total convertible debt of $609k at Dec 2025.

## SEC filing metadata
- accession: 0001640334-26-000461
- form_type: 8-K
- ticker: ARTL
- cik: 0001621221
- company_name: ARTELO BIOSCIENCES, INC.
- filed_at: 2026-03-17T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1621221/000164033426000461/0001640334-26-000461-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1621221/000164033426000461/artl_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001640334-26-000461
- JSON: https://secwatch.observer/filing/0001640334-26-000461.json
- Plain text: https://secwatch.observer/filing/0001640334-26-000461.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.